Get started
SSS

Sonic Healthcare

No trades
See on Supercharts
Overview News
Ideas
Minds

SHL trade ideas

Sonic Healthcare AustraliaSSI Live Trading Series Sun Storm Investment Trading Desk & NexGen Wealth Management Service Present's Focus: Worldwide By Sun Storm Investment Research & NexGen Wealth Management Service A Profit & Solutions Strategy & Research Trading | Investment | Stocks | ETF | Mutual Funds | Crypto | Bonds | Options | Dividend | Futures | USA | Canada | UK | Germany | France | Italy | Rest of Europe | Mexico | India Disclaimer: Sun Storm Investment and NexGen are not registered financial advisors, so please do your own research before trading & investing anything. This is information is for only research purposes not for actual trading & investing decision. #debadipb #profitsolutions
ASX:SHL
by Sunstorminvest
SHL - June displays a strong historical record - Average Gain 4%Sonic Healthcare Ltd is entering a seasonally positive period. Since 2000, the month of June has been unusually kind to SHL, delivering an average gain of 4%, with a win rate of 20 from 22 events, & a standard deviation of 4.1%. Disclaimer: This data is not financial advice. Past performance is not a guide to future performance and may not be repeated. Past performance does not diminish the 'risk' expectancy of any strategy. By its very nature ‘risk’ means you could and most likely will experience losses. No representation or warranty is given as to the accuracy or completeness of any information provided. Data is for educational and informational purposes only.
ASX:SHLLong
by UnknownUnicorn25462132
SHL @ 27 SEP 2021Text me if you have any questions/comments for me. ----- SHL - Previous analysis was done on 13 Sep -> suggested waiting for successful rebound to around 43.00 levels before plotting entry - Since then, the stock did not recover to around 43 levels - Instead, the stock closed below the mid-term support last Friday - In last night’s livestream, I shared that I was still holding the stock and I’m going to risk some of my unrealised gains to see if the stock is capable of an immediate recovery - Today, it closed above the mid-term resistance by the skin of its teeth - I’m still concerned by the lack of buying volume returning -> an important criteria that can drive a strong rebound - A successful rebound will be at 42.50 levels - R is less than 10% - Strategy-to-buy (DYOR) – Suggest waiting for a series of HHs and HLs
ASX:SHL
by Jerm88
SHL found support and now moving higherSonic healthcare looks like a carbon copy of FPH. Found support at 30 with a morning star candle after falling out of channel. 3 very bullish candles on volume now confirming a return to the channel. Targeting 34.60 area as first taregt however POC for the channel sits at 33 which could create some resistance. Long term target would be the top of channel at 36.50ish. MACD has crossed over and RSI looking good with plenty of room to run. For educational purposes only. Do your own research
ASX:SHLLong
by ASXSignalCentre
SHL - Bearish Trend ConfirmationSHL - Bearish Trend Confirmation Indications: 1. The trend has got weak on the Weekly and Monthly with Bearish Engulfing Candles 2. The price has broken the trendline which is confirmation of a bearish trend 3. The down move was a powerful and impulsive wave I expect price to retrace on the upside, and I expect price to get weak at or near (Resistance 1 ~ $34.85 level) or (Resistance 2 ~ $36.75 level), where sellers may attempt to dump the stock and form a Lower High. I expect price to get dumped from either of the Resistance Levels. I believe that buying now is Risky. The ideal level and extremely Strong Support Zone is between ~ $26.50 - ~ $27.30, but it is not necessary that price may drop all the way down to these levels. There may be little swings on the way down but will have to see where SHL finds strong support. I would be a confident buyer at that strong support level for a long term position. Please note these are my own notes, by no means trading advice. Please do your own research before entering into any trade.
ASX:SHLShort
by AsimMirzaTrader
$SHL $SHL.ASX - Double Top , Short term target $26.03SONIC HEALTHCARE LIMITED Double Top , Short term target $26.03 Sonic Healthcare is one of the world's largest medical diagnostics companies, providing laboratory and radiology services to medical practitioners, hospitals, community health services, and their collective patients. P/E 22.640 EPS 1.240 AUD Annual dividend yield Help 3.03 Directors/Senior management Mr Mark R Compton Non Exec. Chairman Dr Colin S Goldschmidt Managing Director, CEO, Executive Director Mr Philip Dubois Executive Director Mr Christopher Wilks Executive Director, Finance Director Mr Neville Mitchell Non Exec. Director Prof. Suzanne Crowe Independent Director Mr Lou Panaccio Independent Director Ms Kate D Spargo Independent Director Dr Jane Wilson Independent Director
ASX:SHLShort
by Abbas39
Sonic Healthcare - Ridiculous Growth Ahead or ? .Fundamentally and technically SHL looks a good stock to add to the portfolio. Currently $24 up side of 10% + to $27+. Entry at 200 EMA OR FIB levels after going ex dividend. On the fundamental side of the equation the latest report was very strong. CEO Colin Goldschmidt said growth is strong particularly in the USA: "I think Sonic is well placed right now for strong growth into the future," "I am especially proud that the revenue of our US business grew 8 per cent organically in the half, which we believe is well above market, driven in part by the success of our hospital laboratory joint ventures and early wins from our billing enhancement system,". CEO'S recent comments also touched on the magnitude of the USA opportunity with no player having more than 5% of the pathology market compared to Australia 76% of the market owned by 2 large players. This makes the USA pathology market a ripe picking ground for SHL acquisitions, said Colin Goldschmidt. On the Technical side volume is strong. The 50 EMA is finally about to cross above the 200 EMA. Both are turning up with higher highs and higher lows being achieved in 2019. Current price is just above Fibonacci levels from recent low. MACD suggests we may see lower prices, however, this is likely due to SHL just going ex dividend. A good entry may be at the 200EMA or at on of the major Fibonacci retracement levels 50 or 61.8. Conclusion: I see SHL's fundamentals & technical outlook perfectly aligning. I dont see much downside risk. As a result, IMO, SHL is a high probabilty of testing the high point seen in 2018 ($27) later in 2019. Let me know what you think of SHL?
ASX:SHLLong
by rutt
2